contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


resolutions-from-the-annual-general-meeting-2026

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Novonesis er aktiv inden for biokemi. Virksomheden udvikler enzymer og mikroorganismer til industriel brug. Enzymerne er et protein, der bruges i en række forskellige industrier, hovedsageligt i landbrugs- og fødevareindustrien. Produkterne bruges til mad og tøj, og salget foregår på globalt plan med den største tilstedeværelse i Norden og Europa. Virksomheden har hovedsæde i Bagsværd.

Novonesis

Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2025Approval of distribution of profit...

Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: <ul><li>Approval of the audited Annual Report for 2025</li><li>Approval of distribution of profit with payment of an ordinary dividend of DKK 4.25 (corresponding to approximately EUR 0.57) per A and B share. In addition to this year-end dividend, an interim dividend of DKK 2.25 (corresponding to approximately EUR 0.3) was disbursed on August 27, 2025</li><li>Approval of the Remuneration Report for 2025 (advisory vote)</li><li>Approval of the remuneration of members of the Board of Directors for 2026</li><li>Re-election of Cornelis (Cees) de Jong as Chair of the Board of Directors</li><li>Re-election of Heine Dalsgaard as Vice Chair of the Boad of Directors</li><li>Re-election of Lise Kaae, Monila Kothari, Kasim Kutay, Kevin Lane, Morten Otto Alexander Sommer, and Kim Stratton as members of the Board of Directors</li><li>Re-election of EY Godkendt Revisionspartnerselskab as the company’s auditors in respect of statutory financial and sustainability reporting</li><li>Approval to renew the authorizations to the Board of Directors to implement capital increases</li><li>Approval to renew the authorization to the Board of Directors to acquire treasury shares</li><li>Approval of the authorization to the Board of Directors to distribute extraordinary dividends</li><li>The shareholder proposal was withdrawn</li></ul> Composition of the Board of Directors and its committees After the Annual General Meeting, the Board of Directors held a board meeting to appoint members of its committees. The Board of Directors, including its committees, continues to be composed as follows: <ul><li>Cees (Cornelis) de Jong (Chair of the Board, chair of the Nomination and Remuneration Committee and member of the Audit Committee)</li><li>Heine Dalsgaard (Vice Chair of the Board and member of the Audit Committee)</li><li>Robert Nøddeskov Jensen (employee representative)</li><li>Lise Kaae (chair of the Audit Committee)</li><li>Monila Kothari (member of the Innovation Committee)</li><li>Kasim Kutay (member of the Nomination and Remuneration Committee)</li><li>Lars Bo Køppler (employee representative and member of the Nomination and Remuneration Committee)</li><li>Kevin Lane (member of the Innovation Committee)</li><li>Preben Nielsen (employee representative and member of the Innovation Committee)</li><li>Frederikke Rose Spenner (employee representative)</li><li>Morten Otto Alexander Sommer (chair of the Innovation Committee)</li><li>Kim Stratton (member of the Nomination and Remuneration Committee)</li></ul> For further information on the members of the Board of Directors, please go to <a href="https://www.globenewswire.com/Tracker?data=SQ00y0YjaD0s_gnWKk6bhuO9LoPOs8bH5xUgUYPcxikdm-gpX1Mae76Wg7HP9Qx1br9kXtkzeYdbFT6vdwvznXUwckqdpQ2uDctsfYJmuRY=">www.novonesis.com</a> Attachment<ul> <li> <a href="https://ml-eu.globenewswire.com/Resource/Download/01e7e1ea-d193-48a9-a262-876f1a4b759d">2026_09_AGM_Resolutions</a> </li> </ul><img alt="" src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMTE3MTcyNSM0MDIzNjI5NzIjMjAwMjM5NA=="> <img alt="" src="https://ml-eu.globenewswire.com/media/Y2YzMWIxMmQtOGFkYS00OWI5LThiYTAtZjFhOTMxZGI2YjgxLTEwMTM5NjctMjAyNi0wMy0yMy1lbg==/tiny/Novonesis-Novozymes-A-S-.png">

Resolutions from the Annual General Meeting 2026

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Nordea Bank

Aktionær i Nordea? Det er nemmere end nogensinde at deltage i Nordeas generalforsamling takket være nyt digitalt setup

Return on capital (ROE, ROI, ROIC, RONIC)

Balance sheet, debt leverage and risks